Our Entrepreneurs

Leonardo Olivera

Laboratorios Clausen

Leonardo Olivera Leonardo Olivera

Impact metric

307% growth in jobs since selection
“I saw an opportunity to advance cancer research in Uruguay.
Country
Uruguay
Industry
Health Care/Life Sciences
Employees
137
partner
Gabriel Fernández
Website

Company Snapshot

Laboratorios Clausen is the first and only Uruguayan biotech firm to develop an entirely new molecule. Thrombopoetin, a human protein that stimulates the production of platelets, was patented in 1998. Today it is used in treatments for cancer and blood coagulation disorders. To elevate Laboratorios Clausen to the next level, Gabriel and Leonardo have constructed a state-of-the-art production facility that is one of only three EMEA Certified facilities in Latin America. Clausen was the subject of a Universidad ORT Uruguay case study.

Since selection by Endeavor, company revenues have grown by 256%.

Endeavor and LEONARDO OLIVERA

Leonardo and Gabriel have benefited from local strategic mentorship, support in strengthening their patent applications, custom workshops on management issues, and introductions to local business leaders to help foster the country’s biotech industry. They also benefited from the Ernst & Young Fellows program, and the eMBA program which developed a business plan for new patents and methods of seeking capital.

The Entrepreneurs have demonstrated commitment by participating as speakers at Endeavor events, and screening candidates.

From the Entrepreneurship Blog

Events

Endeavor Named Most Impactful Company in Latin America by LATAM Founders Network

March 29th, 2015 — by admin

The LATAM Founders Network (LFN), a network for CEOs, partners and founders focused on the investment and technology space in Latin America, recently named Endeavor as the "Most Impactful" organiz…

Read more

In the news

Endeavor Awarded the 2015 Henry R. Kravis Prize in Nonprofit Leadership

March 31st, 2015 — by admin

In recognition of Endeavor's work providing support and mentorship to over a thousand high-impact entrepreneurs in 22 markets around the world, the organization has been named the recipient of the 10t…

Read more

Contact us

Press center

Community

Newsletter Sign Up